Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-17-000090
Filing Date
2017-05-25
Accepted
2017-05-25 16:18:09
Documents
2
Period of Report
2017-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149574347356195.html 4  
1 FORM 4 wf-form4_149574347356195.xml 4 14139
2 POWER OF ATTORNEY - ROTHERA ex-24.htm EX-24 4086
  Complete submission text file 0001070081-17-000090.txt   19708
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Rothera Mark (Reporting) CIK: 0001550424 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 17870217